Title
Comparison of next-generation portable pollution monitors to measure exposure to PM2.5 from household air pollution in Puno, Peru
Date Issued
01 May 2020
Access level
open access
Resource Type
journal article
Author(s)
Burrowes V.J.
Piedrahita R.
Pillarisetti A.
Underhill L.J.
Fandiño-Del-Rio M.
Johnson M.
Kephart J.L.
Steenland K.
Naeher L.
Kearns K.
Peel J.L.
Clark M.L.
Checkley W.
Nambajimana A.
Verma A.
Lovvorn A.
Diaz A.
Papageorghiou A.
Toenjes A.
Quinn A.
Nizam A.
Ryan B.
Young B.
Barr D.
Goodman D.
Canuz E.
Puzzolo E.
McCollum E.
Mollinedo E.
Majorin F.
Ndagijimana F.
Rosa G.
Thangavel G.
Chang H.
Fuentes I.S.P.
Ntivuguruzwa J.d.D.
Uwizeyimana J.
Peel J.L.
Sarnat J.
Liao J.
McCracken J.
Rosenthal J.
Espinoza J.G.
Campbell J.M.P.
Balakrishnan K.
Smith K.
Mukhopadhyay K.
Waller L.
Moulton L.
Jaacks L.
Elon L.
Thompson L.
Laws M.
Howard M.
Crocker M.
Kirby M.
Puttaswamy N.
De Leon O.
Herrera P.
Craik R.
Merrick R.
Sambandam S.
Garg S.
Rajkumar S.
Gupton S.
Hossen S.
Sinharoy S.
Jabbarzadeh S.
Harvey S.
Simkovich S.
Clasen T.
Ramakrishnan U.
Davila-Roman V.G.
Aravindalochanan V.
Chen Y.
Sakas Z.
Publisher(s)
John Wiley and Sons Inc
Abstract
Assessment of personal exposure to PM2.5 is critical for understanding intervention effectiveness and exposure-response relationships in household air pollution studies. In this pilot study, we compared PM2.5 concentrations obtained from two next-generation personal exposure monitors (the Enhanced Children MicroPEM or ECM; and the Ultrasonic Personal Air Sampler or UPAS) to those obtained with a traditional Triplex Cyclone and SKC Air Pump (a gravimetric cyclone/pump sampler). We co-located cyclone/pumps with an ECM and UPAS to obtain 24-hour kitchen concentrations and personal exposure measurements. We measured Spearmen correlations and evaluated agreement using the Bland-Altman method. We obtained 215 filters from 72 ECM and 71 UPAS co-locations. Overall, the ECM and the UPAS had similar correlation (ECM ρ = 0.91 vs UPAS ρ = 0.88) and agreement (ECM mean difference of 121.7 µg/m3 vs UPAS mean difference of 93.9 µg/m3) with overlapping confidence intervals when compared against the cyclone/pump. When adjusted for the limit of detection, agreement between the devices and the cyclone/pump was also similar for all samples (ECM mean difference of 68.8 µg/m3 vs UPAS mean difference of 65.4 µg/m3) and personal exposure samples (ECM mean difference of −3.8 µg/m3 vs UPAS mean difference of −12.9 µg/m3). Both the ECM and UPAS produced comparable measurements when compared against a cyclone/pump setup.
Start page
445
End page
458
Volume
30
Issue
3
Language
English
OCDE Knowledge area
Salud pública, Salud ambiental
Subjects
Scopus EID
2-s2.0-85078657173
PubMed ID
Source
Indoor Air
ISSN of the container
09056947
Sponsor(s)
The HAPIN trial and this pilot study are funded by the US National Institutes of Health (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation [OPP1131279]. We would also like to thank the Fogarty International Center (UJMT FGHF Grant D43TW009340), the field research assistants from the Asociación Benéfica PRISMA and study participants in Puno, Peru, for their contributions to this research. Finally, we would like to extend a special thank you to Elena Rosa Morales‐Hinojosa for her significant contributions and attention to quality throughout this pilot study. A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Nancy R. Cook, Sc.D.; Stephen Hecht, PhD; Catherine Karr, MD, PhD; Katie H. Kavounis, MPH; Dong‐Yun Kim, PhD; Joseph Millum, PhD; Lora A. Reineck, MD, MS; Nalini Sathiakumar, MD, DrPH; Paul K. Whelton, MD; Gail G. Weinmann, MD Program Coordination: Gail Rodgers, MD, Bill & Melinda Gates Foundation; Claudia L. Thompson, PhD National Institute of Environmental Health Science (NIEHS); Mark J. Parascandola, PhD, MPH, National Cancer Institute (NCI); Danuta M. Krotoski, PhD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Joshua P. Rosenthal, PhD Fogarty International Center (FIC), Conception R. Nierras, PhD NIH Office of Strategic Coordination Common Fund; Antonello Punturieri, MD, PhD and Barry S. Schmetter, National Heart, Lung, and Blood Institute (NHLBI). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services. None of the authors have conflicts of interest to declare.
The HAPIN trial and this pilot study are funded by the US National Institutes of Health (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation [OPP1131279]. We would also like to thank the Fogarty International Center (UJMT FGHF Grant D43TW009340), the field research assistants from the Asociación Benéfica PRISMA and study participants in Puno, Peru, for their contributions to this research. Finally, we would like to extend a special thank you to Elena Rosa Morales-Hinojosa for her significant contributions and attention to quality throughout this pilot study. A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: Nancy R. Cook, Sc.D.; Stephen Hecht, PhD; Catherine Karr, MD, PhD; Katie H. Kavounis, MPH; Dong-Yun Kim, PhD; Joseph Millum, PhD; Lora A. Reineck, MD, MS; Nalini Sathiakumar, MD, DrPH; Paul K. Whelton, MD; Gail G. Weinmann, MD Program Coordination: Gail Rodgers, MD, Bill & Melinda Gates Foundation; Claudia L. Thompson, PhD National Institute of Environmental Health Science (NIEHS); Mark J. Parascandola, PhD, MPH, National Cancer Institute (NCI); Danuta M. Krotoski, PhD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Joshua P. Rosenthal, PhD Fogarty International Center (FIC), Conception R. Nierras, PhD NIH Office of Strategic Coordination Common Fund; Antonello Punturieri, MD, PhD and Barry S. Schmetter, National Heart, Lung, and Blood Institute (NHLBI). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health or Department of Health and Human Services. None of the authors have conflicts of interest to declare.
Sources of information:
Directorio de Producción Científica
Scopus